(Q42526596)

1 November 2017

title

Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems (English)

1 reference

1 November 2017

7

1 reference

1 November 2017

Nicholas MacInnes

1

1 reference

1 November 2017

Mahmoud M Iravani

2

1 reference

1 November 2017

Elaine Perry

3

1 reference

1 November 2017

Margaret Piggott

4

1 reference

1 November 2017

Robert Perry

5

1 reference

1 November 2017

Peter Jenner

6

1 reference

1 November 2017

publication date

10 April 2008

1 reference

Journal of Neural Transmission

1 November 2017

published in

1 reference

1 November 2017

volume

115

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

869-878

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-008-0027-6

1 November 2017

exact match

0 references

cites work

Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Proteasome dysfunction in mammalian aging: steps and factors involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Alpha-synuclein and transgenic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Proteasome inhibition causes nigral degeneration with inclusion bodies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Selective loss of 20S proteasome alpha-subunits in the substantia nigra pars compacta in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

The prevalence and phenomenology of psychotic symptoms in dementia sufferers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-008-0027-6

Failure of the ubiquitin-proteasome system in Parkinson's disease

21 January 2018

1 reference

12 December 2020

Animal models of Parkinson's disease in rodents induced by toxins: an update

1 reference

12 December 2020

Fine Structure and Biochemical Mechanisms Underlying Nigrostriatal Inclusions and Cell Death after Proteasome Inhibition

1 reference

12 December 2020

A systematic review of prevalence studies of dementia in Parkinson's disease

1 reference

12 December 2020

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.

1 reference

12 December 2020

Proteasomal function is impaired in substantia nigra in Parkinson's disease

1 reference

12 December 2020

Angiotensin II decreases cGMP levels in neuronal cultures from rat brain

1 reference

12 December 2020

The origin of tyrosine hydroxylase-immunoreactive fibers in the regions of the nucleus basalis magnocellularis of the rat

1 reference

12 December 2020

Cyclin-dependent kinase activity is required for apoptotic death but not inclusion formation in cortical neurons after proteasomal inhibition.

1 reference

12 December 2020

The proteasomal inhibition model of Parkinson's disease: "Boon or bust"?

1 reference

12 December 2020

10.1007/S00702-008-0027-6

Identifiers

DOI

1 reference

1 November 2017

1 reference